The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
objectives of the present study were (a) to study the probability of developing clinical criteria …

OBJECTIVE: We carried out a prospective analysis of clinical and analytical findings in
individuals with antiphospholipid antibodies (aPL). METHODS: We prospectively studied …

Antiphospholipid syndrome is a systemic autoimmune disorder characterized by vascular
thrombosis and/or obstetric events in association with persistently elevated antiphospholipid …

Abstract Purpose of Review The epidemiology of antiphospholipid syndrome (APS) is poorly
understood. Here, we review the current understanding of the epidemiology of …

This issue of Seminars in Thrombosis & Hemostasis is devoted to antiphospholipid (aPL)
antibodies and the antiphospholipid syndrome (APS). aPL antibodies are well-recognized …

Objective Obstetric complications are common in patients with antiphospholipid syndrome.
However, the impact of antiphosholipid antibodies (aPL) in the pregnancy outcomes of …

Objective: To determine the risk of antiphospholipid antibody-related disorders in women
with elevated levels of these antibodies. Methods: We used an historic cohort study design …

Antiphospholipid antibody syndrome (APS) is characterized by autoantibodies against
negatively charged phospholipids in the serum, and clinically by multiple thromboses …

Background Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is
caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2 glycoprotein-I …

The antiphospholipid syndrome (APS) is defined by the occurrence of venous and arterial
thromboses, often multiple, and recurrent fetal losses, frequently accompanied by a …